• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS CMV IGG ASSAY; ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS CMV IGG ASSAY; ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS Back to Search Results
Catalog Number 07027117190
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/23/2021
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).The patient's sample was provided for an investigation.The investigation is ongoing.Unique device identifier (udi): (b)(4).
 
Event Description
The initial reporter received questionable elecsys cmv igg assay results for one patient tested on a cobas 8000 e 801 module serial number (b)(4).The patient's initial elecsys cmv igg result was reported outside the laboratory.The patient's physician questioned the elecsys cmv igg result due to the result not matching the patient's clinical status.The customer repeated the sample on a mikrogen recom line wester blot analyzer.Also, the patient's sample was sent to a different laboratory and was tested on an e 801 module.On (b)(6) 2021, the patient's initial elecsys cmv igg result was 1.32 u/ml reactive.The patient's repeat cmv igg result on the mikrogen recom line wester blot analyzer was non-reactive.The date of measurement was requested but not provided.On (b)(6) 2021, the patient's second repeat cmv igg result on a different e 801 module was 1.24 u/ml reactive.
 
Manufacturer Narrative
The customer's calibration and qc data were requested but not provided.The investigation performed further testing with the patient's sample.The patient's recomline cmv igg was negative.The patient's cmv igg submodule assay result was dominant reactivity to module 4.The investigation determined the sample caused a false reactive result with the elecsys cmv igg assay due to an unspecified interferent.The patient should be considered seronegative for cmv.Based on the specificity of the elecsys cmv igg assay, false positives can occur.The investigation did not identify a product problem.
 
Manufacturer Narrative
The investigation tested the patient's sample and received the following results: cmv igm: 0.143 coi non-reactive cmv igg: 1.35 u/ml reactive cmv igg avidity: 84.3 % the investigation confirmed the customer's results.Based on the available information, a general reagent issue could be excluded.The investigation is ongoing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS CMV IGG ASSAY
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11672502
MDR Text Key269787721
Report Number1823260-2021-01149
Device Sequence Number1
Product Code LFZ
Combination Product (y/n)N
PMA/PMN Number
K131605
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 06/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/15/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07027117190
Device Lot Number52258300
Was Device Available for Evaluation? Yes
Date Manufacturer Received03/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age35 YR
-
-